SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-208037
Filing Date
2020-08-03
Accepted
2020-08-03 16:06:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d45176dsc13da.htm SC 13D/A 37674
  Complete submission text file 0001193125-20-208037.txt   39292
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81104 | Film No.: 201069262
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACER THERAPEUTICS INC. 222 THIRD STREET CAMBRIDGE MA 02142
Business Address
Schelling Chris (Filed by) CIK: 0001717241 (see all company filings)

Type: SC 13D/A